A client taking alosetron reports new constipation and cramping lower abdominal pain. What should the nurse instruct the client to do?
1Increase the next dose to restore bowel regularity, then reassess the abdominal symptoms after 48 hours.
2Stop the medication now and contact the prescriber for evaluation of a serious bowel complication or ischemic colitis.✓ Correct answer
3Continue the current dose while monitoring for rectal bleeding, fever, or worsening abdominal tenderness.
4Take an opioid antidiarrheal with the next dose and increase dietary fiber until bowel movements resume.
Explanation
Alosetron must be stopped immediately when constipation or signs of ischemic colitis develop. Serious bowel complications can occur without waiting for rectal bleeding.
Quick answer Use new constipation or ischemic-colitis cues as an alosetron stop rule.
Why this is correct Continuing the drug or adding another bowel-slowing agent can worsen obstruction or ischemia.
Easy analogy or mental picture Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.
Memory hook Drug, urgent cue, protective action, and reassessment endpoint.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrong Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: LOTRONEX (alosetron)Immediate discontinuation for constipation or ischemic-colitis symptoms
Medication-safety reviewVerify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.